Inhalte Newsletter2023s
Displaying 6621-6630 of 7032 results.
ID:
6769
Newsletter 2023: 653
Element: 12973
Position: 2
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dap-fortbildungen/clusterkopfschmerz/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAP-Fortbildung-Clusterkopfschmerz.jpg" alt="DAP FORTBILDUNG Clusterkopfschmerz" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP FORTBILDUNG Clusterkopfschmerz"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 12973
Position: 2
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dap-fortbildungen/clusterkopfschmerz/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAP-Fortbildung-Clusterkopfschmerz.jpg" alt="DAP FORTBILDUNG Clusterkopfschmerz" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP FORTBILDUNG Clusterkopfschmerz"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6770
Newsletter 2023: 653
Element: 13112
Position: 3
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:6px;padding-top:6px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Jetzt von 1 A Pharma und Hexal </h2> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;background-color:#ffffff;padding-top:20px;padding-bottom:0px;"> <!--[if mso]> <table style="width:660px" cellpadding="0" cellspacing="0"> <tr> <td style="width:340px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:340px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Ab sofort steht Ihnen der Wirkstoff <b>Nintedanib auch von 1 A Pharma und Hexal</b> einmal in der Onkologie<sup style="line-height:0;">1</sup> bzw. in der Pneumologie<sup style="line-height:0;">2</sup> zur Verfügung:</p> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0;"> <ul style="margin-bottom: 0;"> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup></b> beim nicht-kleinzelligen Lungenkarzinom <b>(NSCLC)</b><sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;"><b>Nintedanib Hexal<sup style="line-height:0;">®</sup></b> bei idiopathischer Lungenfibrose <b>(IPF)</b><sup style="line-height:0;">2</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;">Indikationsgleich zu den Erstanbietern <b>Vargatef<sup style="line-height:0;">®</sup></b><sup style="line-height:0;">1,3</sup> und <b>Ofev<sup style="line-height:0;">®</sup></b><sup style="line-height:0;">2,4</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;">Partner in <b>allen</b> ausgeschriebenen Rabattverträgen<sup style="line-height:0;">#</sup></li> </ul> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> <td style="width:20px"></td> <td style="width:320px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:320px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;font-size:0" class="pt-20 pr-0"><img class="adapt-img" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2026q2/newsletter_2026-04-08_g3.jpg"></td> </tr> <tr> <td align="right" class="es-text-3633" style="padding:0;Margin:0;padding-right:20px;font-size:12px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#555;font-size:12px">© Hexal AG</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> </tr> </table> <![endif]--> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Weitere Informationen finden Sie auf den Websites:</p> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"> <a href="https://www.1apharma.de/produkte/nintedanib-1-a-pharma/?utm_medium=email&utm_source=newsletter&utm_campaign=Nintedanib_Launch_DAP2&utm_term=oncology" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"><a href="https://www.hexal.de/produkte/nintedanib-hexal/?utm_medium=email&utm_source=newsletter&utm_campaign=Nintedanib_Launch_DAP1&utm_term=respiratory" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Nintedanib HEXAL<sup style="line-height:0;">®</sup></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">1 Zugelassene Indikationen entnehmen Sie bitte der Fachinformation Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup>, Stand: November 2025.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">2 Zugelassene Indikationen entnehmen Sie bitte der Fachinformation Nintedanib HEXAL<sup style="line-height:0;">®</sup>, Stand: Dezember 2025.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">3 Fachinformation Vargatef <sup style="line-height:0;">®</sup>, Stand: Juli 2024. Vargatef<sup style="line-height:0;">®</sup> ist eine eingetragene Marke der Boehringer Ingelheim International GmbH.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">4 Fachinformation Ofev<sup style="line-height:0;">®</sup>, Stand: März 2025</p></td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:5px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"># TED und ASP Monitor: Alle entsprechend ausgeschriebenen Nintedanib-GKV-Rabattverträge betreffen 100/- 150 mg Weichkapseln.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.deutschesapothekenportal.de/newsletter/2026q2/pt_nintedanib-1a-pharma.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup> (PDF)</a></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.deutschesapothekenportal.de/newsletter/2026q2/pt_nintedanib-hexal.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Nintedanib HEXAL<sup style="line-height:0;">®</sup> (PDF)</a></p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 13112
Position: 3
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:6px;padding-top:6px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Jetzt von 1 A Pharma und Hexal </h2> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;background-color:#ffffff;padding-top:20px;padding-bottom:0px;"> <!--[if mso]> <table style="width:660px" cellpadding="0" cellspacing="0"> <tr> <td style="width:340px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:340px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Ab sofort steht Ihnen der Wirkstoff <b>Nintedanib auch von 1 A Pharma und Hexal</b> einmal in der Onkologie<sup style="line-height:0;">1</sup> bzw. in der Pneumologie<sup style="line-height:0;">2</sup> zur Verfügung:</p> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0;"> <ul style="margin-bottom: 0;"> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup></b> beim nicht-kleinzelligen Lungenkarzinom <b>(NSCLC)</b><sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;"><b>Nintedanib Hexal<sup style="line-height:0;">®</sup></b> bei idiopathischer Lungenfibrose <b>(IPF)</b><sup style="line-height:0;">2</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;">Indikationsgleich zu den Erstanbietern <b>Vargatef<sup style="line-height:0;">®</sup></b><sup style="line-height:0;">1,3</sup> und <b>Ofev<sup style="line-height:0;">®</sup></b><sup style="line-height:0;">2,4</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px; margin-top:10px;">Partner in <b>allen</b> ausgeschriebenen Rabattverträgen<sup style="line-height:0;">#</sup></li> </ul> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> <td style="width:20px"></td> <td style="width:320px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:320px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;font-size:0" class="pt-20 pr-0"><img class="adapt-img" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2026q2/newsletter_2026-04-08_g3.jpg"></td> </tr> <tr> <td align="right" class="es-text-3633" style="padding:0;Margin:0;padding-right:20px;font-size:12px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#555;font-size:12px">© Hexal AG</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> </tr> </table> <![endif]--> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Weitere Informationen finden Sie auf den Websites:</p> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"> <a href="https://www.1apharma.de/produkte/nintedanib-1-a-pharma/?utm_medium=email&utm_source=newsletter&utm_campaign=Nintedanib_Launch_DAP2&utm_term=oncology" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"><a href="https://www.hexal.de/produkte/nintedanib-hexal/?utm_medium=email&utm_source=newsletter&utm_campaign=Nintedanib_Launch_DAP1&utm_term=respiratory" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Nintedanib HEXAL<sup style="line-height:0;">®</sup></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">1 Zugelassene Indikationen entnehmen Sie bitte der Fachinformation Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup>, Stand: November 2025.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">2 Zugelassene Indikationen entnehmen Sie bitte der Fachinformation Nintedanib HEXAL<sup style="line-height:0;">®</sup>, Stand: Dezember 2025.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">3 Fachinformation Vargatef <sup style="line-height:0;">®</sup>, Stand: Juli 2024. Vargatef<sup style="line-height:0;">®</sup> ist eine eingetragene Marke der Boehringer Ingelheim International GmbH.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">4 Fachinformation Ofev<sup style="line-height:0;">®</sup>, Stand: März 2025</p></td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:5px;padding-left:20px;padding-top:5px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"># TED und ASP Monitor: Alle entsprechend ausgeschriebenen Nintedanib-GKV-Rabattverträge betreffen 100/- 150 mg Weichkapseln.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.deutschesapothekenportal.de/newsletter/2026q2/pt_nintedanib-1a-pharma.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Nintedanib – 1 A Pharma<sup style="line-height:0;">®</sup> (PDF)</a></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.deutschesapothekenportal.de/newsletter/2026q2/pt_nintedanib-hexal.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Nintedanib HEXAL<sup style="line-height:0;">®</sup> (PDF)</a></p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6771
Newsletter 2023: 653
Element: 12728
Position: 4
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dap-fortbildungen/pilz-und-ekzemerkrankungen/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAP-Fortbildung-Dermapharm-Ketozolin.jpg" alt="DAP FORTBILDUNG Kompetente Beratung bei seborrhoischem Ekzem und Kleienpilzflechte" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP FORTBILDUNG Kompetente Beratung bei seborrhoischem Ekzem und Kleienpilzflechte"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 12728
Position: 4
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dap-fortbildungen/pilz-und-ekzemerkrankungen/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAP-Fortbildung-Dermapharm-Ketozolin.jpg" alt="DAP FORTBILDUNG Kompetente Beratung bei seborrhoischem Ekzem und Kleienpilzflechte" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP FORTBILDUNG Kompetente Beratung bei seborrhoischem Ekzem und Kleienpilzflechte"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6772
Newsletter 2023: 653
Element: 12571
Position: 6
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/beratung/beratungsleitfaeden/maennergesundheit/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Beratungsleitfaden-Maennergesundheit.png" alt="zum Beratungsleitfaden" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Beratungsleitfaden"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 12571
Position: 6
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/beratung/beratungsleitfaeden/maennergesundheit/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Beratungsleitfaden-Maennergesundheit.png" alt="zum Beratungsleitfaden" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Beratungsleitfaden"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6773
Newsletter 2023: 653
Element: 13119
Position: 7
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:6px;padding-top:6px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Neu in der Fresubin<sup style="line-height:0;">®</sup>-Familie: Fresubin<sup style="line-height:0;">®</sup> 2 kcal Drink Erdbeere</h2> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;background-color:#ffffff;padding-top:20px;padding-bottom:0px;"> <!--[if mso]> <table style="width:660px" cellpadding="0" cellspacing="0"> <tr> <td style="width:340px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:340px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Fresubin<sup style="line-height:0;">®</sup> bringt zuverlässige Energie für Tage, die ein bisschen mehr verlangen.</p> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Entdecken Sie die Geschmacksrichtung Erdbeere (PZN: 19222766) als neuen Teil der fruchtigen Fresubin<sup style="line-height:0;">®</sup> 2 kcal Drink Geschmackswelt – leicht, aromatisch und einfach lecker.<img src="https://track.adform.net/adfserve/?bn=88096527;1x1inv=1;srctype=3;ord=[timestamp]" border="0" width="1" height="1"></p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> <td style="width:20px"></td> <td style="width:320px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:320px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;font-size:0" class="pt-20 pr-0"><a href="https://www.fresubin.com/de/produkte/fresubin-2-kcal-drink?utm_source=DAP&utm_medium=Newsletter&utm_campaign=Fr%C3%BChling/Sommer26." target="_blank"><img class="adapt-img" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2026q2/newsletter_2026-04-01_g1.jpg"></a></td> </tr> <tr> <td align="right" class="es-text-3633" style="padding:0;Margin:0;padding-right:20px;font-size:12px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#555;font-size:12px">© Fresenius Kabi Deutschland GmbH</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> </tr> </table> <![endif]--> </td> </tr> <tr> <td align="center" style="Margin:0; padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a target="_blank" href="https://track.adform.net/C/?bn=88096527" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Mehr erfahren Sie unter fresubin.de</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 13119
Position: 7
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:6px;padding-top:6px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Neu in der Fresubin<sup style="line-height:0;">®</sup>-Familie: Fresubin<sup style="line-height:0;">®</sup> 2 kcal Drink Erdbeere</h2> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;background-color:#ffffff;padding-top:20px;padding-bottom:0px;"> <!--[if mso]> <table style="width:660px" cellpadding="0" cellspacing="0"> <tr> <td style="width:340px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:340px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Fresubin<sup style="line-height:0;">®</sup> bringt zuverlässige Energie für Tage, die ein bisschen mehr verlangen.</p> </td> </tr> <tr> <td align="left" bgcolor="transparent" style="padding:0;Margin:0;padding-right:0;padding-left:20px;padding-right:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Entdecken Sie die Geschmacksrichtung Erdbeere (PZN: 19222766) als neuen Teil der fruchtigen Fresubin<sup style="line-height:0;">®</sup> 2 kcal Drink Geschmackswelt – leicht, aromatisch und einfach lecker.<img src="https://track.adform.net/adfserve/?bn=88096527;1x1inv=1;srctype=3;ord=[timestamp]" border="0" width="1" height="1"></p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> <td style="width:20px"></td> <td style="width:320px" valign="top"> <![endif]--> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:320px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;font-size:0" class="pt-20 pr-0"><a href="https://www.fresubin.com/de/produkte/fresubin-2-kcal-drink?utm_source=DAP&utm_medium=Newsletter&utm_campaign=Fr%C3%BChling/Sommer26." target="_blank"><img class="adapt-img" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2026q2/newsletter_2026-04-01_g1.jpg"></a></td> </tr> <tr> <td align="right" class="es-text-3633" style="padding:0;Margin:0;padding-right:20px;font-size:12px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#555;font-size:12px">© Fresenius Kabi Deutschland GmbH</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <!--[if mso]> </td> </tr> </table> <![endif]--> </td> </tr> <tr> <td align="center" style="Margin:0; padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a target="_blank" href="https://track.adform.net/C/?bn=88096527" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Mehr erfahren Sie unter fresubin.de</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6774
Newsletter 2023: 653
Element: 11587
Position: 8
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/rezept-retax/retax-arbeitshilfen/impfen-in-der-apotheke/erstattungsfaehigkeit-rsv-impfstoffe/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Arbeitshilfe-Erstattungsfaehigkeit-von-RSV-Impfstoffen.jpg" alt="" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 11587
Position: 8
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/rezept-retax/retax-arbeitshilfen/impfen-in-der-apotheke/erstattungsfaehigkeit-rsv-impfstoffe/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Arbeitshilfe-Erstattungsfaehigkeit-von-RSV-Impfstoffen.jpg" alt="" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6775
Newsletter 2023: 653
Element: 13175
Position: 9
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/tages/tagesfrage_1.jpg" alt="Aktuelle Retaxfrage" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Aktuelle Retaxfrage"></td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555">APOTHEKE FRAGT – DAP ANTWORTET</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Ovestin oder OeKolp forte – OVU oder VSU?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:15px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Wir haben ein Entlassrezept über Ovestin Ovula 15 St. N2 zulasten der BIG direkt gesund (IK: 103501080) vorgelegt bekommen. Wir sind uns nun unsicher, ob wir dieses so beliefern können, da die Darreichungsform OVU ist. Es gibt nämlich auch OeKolp 10 St. N1, das als VSU gekennzeichnet ist.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Wir hoffen Sie können uns helfen.</p> </td> </tr> <tr> <td align="center" style="Margin:0; padding: 20px 20px 20px 20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a target="_blank" href="https://www.deutschesapothekenportal.de/rezept-retax/apothekenfragen-archiv/vollstaendiger-beitrag/ovestin-oder-oekolp-forte-ovu-oder-vsu/" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Lesen Sie hier die Antwort</a> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: Stokkete/Shutterstock.com</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 13175
Position: 9
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/tages/tagesfrage_1.jpg" alt="Aktuelle Retaxfrage" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Aktuelle Retaxfrage"></td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555">APOTHEKE FRAGT – DAP ANTWORTET</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">Ovestin oder OeKolp forte – OVU oder VSU?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:15px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Wir haben ein Entlassrezept über Ovestin Ovula 15 St. N2 zulasten der BIG direkt gesund (IK: 103501080) vorgelegt bekommen. Wir sind uns nun unsicher, ob wir dieses so beliefern können, da die Darreichungsform OVU ist. Es gibt nämlich auch OeKolp 10 St. N1, das als VSU gekennzeichnet ist.</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Wir hoffen Sie können uns helfen.</p> </td> </tr> <tr> <td align="center" style="Margin:0; padding: 20px 20px 20px 20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a target="_blank" href="https://www.deutschesapothekenportal.de/rezept-retax/apothekenfragen-archiv/vollstaendiger-beitrag/ovestin-oder-oekolp-forte-ovu-oder-vsu/" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Lesen Sie hier die Antwort</a> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: Stokkete/Shutterstock.com</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6776
Newsletter 2023: 653
Element: 13130
Position: 10
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dapssst/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAPssst_GALENpharma-DuoAllerg.jpg" alt="" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 13130
Position: 10
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/dapssst/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_DAPssst_GALENpharma-DuoAllerg.jpg" alt="" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
ID:
6777
Newsletter 2023: 653
Element: 13176
Position: 11
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"> <span style="background:transparent">Anzeige</span> </p> </td> </tr> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"> <img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/2023q3/newsletter_2023-08-19_g2.jpg" alt="Apofrage des Tages" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555"> APOFRAGE DES TAGES</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">In welcher Darreichungsform wird Ivermectin zur Behandlung der Rosazea üblicherweise angewendet?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Bei richtiger Antwort werden Ihnen 5 DAPs-Punkte gutgeschrieben.</p> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://www.deutschesapothekenportal.de/wissen/apofrage-des-tages/" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Apofrage des Tages</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"><a href="https://www.meindap.de/apofrage_2026-04-28_aliud-ivermectin_infos" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Zu den Produktinformationen*</a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">* Login erforderlich</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.meindap.de/apofrage_2026-04-28_aliud-ivermectin_pt" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Ivermectin AL Creme (PDF)</a><br></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: DAP Networks GmbH</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table></td></tr></tbody></table>
Newsletter 2023: 653
Element: 13176
Position: 11
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"> <span style="background:transparent">Anzeige</span> </p> </td> </tr> <tr> <td align="left" style="padding:0;Margin:0;font-size:0"> <img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/2023q3/newsletter_2023-08-19_g2.jpg" alt="Apofrage des Tages" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title=""> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#555555"> APOFRAGE DES TAGES</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">In welcher Darreichungsform wird Ivermectin zur Behandlung der Rosazea üblicherweise angewendet?</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px !important;letter-spacing:0;color:#555555;font-size:14px">Bei richtiger Antwort werden Ihnen 5 DAPs-Punkte gutgeschrieben.</p> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://www.deutschesapothekenportal.de/wissen/apofrage-des-tages/" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Apofrage des Tages</a> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:300px" class="pt-20"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#eeeeee"><a href="https://www.meindap.de/apofrage_2026-04-28_aliud-ivermectin_infos" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #000; text-decoration: none;background-color: #eeeeee; padding: 10px 20px; border: 1px solid #eeeeee; display: block;">Zu den Produktinformationen*</a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">* Login erforderlich</p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:0px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">» <a href="https://www.meindap.de/apofrage_2026-04-28_aliud-ivermectin_pt" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;font-size:11px;color:#005CA9;word-break:break-all;">Pflichttext Ivermectin AL Creme (PDF)</a><br></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:10px;padding-left:20px;padding-top:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">Bildquelle: DAP Networks GmbH</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table></td></tr></tbody></table>
ID:
6778
Newsletter 2023: 653
Element: 9937
Position: 12
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;padding-left:20px;"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:380px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><strong>Hinweis:</strong> Anregungen, Kritik und Themenwünsche zum Newsletter können gerne per Mail an <a href="mailto:info@deutschesapothekenportal.de" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9">info@deutschesapothekenportal.de</a> geschickt werden<a href="https://www.meindap.de/apo-nl-cleverreach" target="_blank" style="color:#555555; text-decoration: none">.</a> Wir freuen uns auf Ihr Feedback!</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:180px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;font-size:0"><img src="https://www.deutschesapothekenportal.de/newsletter/icons/email_Icon.png" alt="Mail-Symbol" height="70" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none"></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Newsletter 2023: 653
Element: 9937
Position: 12
Html: <table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;padding-right:20px;padding-left:20px;"> <table class="es-content-body" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:#e0e0e0;width:660px" cellspacing="0" cellpadding="0" bgcolor="#e0e0e0" align="center"> <tbody> <tr> <td align="left" bgcolor="#ffffff" style="Margin:0;padding-right:20px;padding-left:20px;padding-bottom:20px;padding-top:20px;background-color:#ffffff"> <table cellpadding="0" cellspacing="0" class="es-left" align="left" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:left"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:380px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><strong>Hinweis:</strong> Anregungen, Kritik und Themenwünsche zum Newsletter können gerne per Mail an <a href="mailto:info@deutschesapothekenportal.de" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9">info@deutschesapothekenportal.de</a> geschickt werden<a href="https://www.meindap.de/apo-nl-cleverreach" target="_blank" style="color:#555555; text-decoration: none">.</a> Wir freuen uns auf Ihr Feedback!</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> <table cellpadding="0" cellspacing="0" class="es-right" align="right" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;float:right"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;width:180px"> <table cellpadding="0" cellspacing="0" width="100%" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td align="center" style="padding:0;Margin:0;font-size:0"><img src="https://www.deutschesapothekenportal.de/newsletter/icons/email_Icon.png" alt="Mail-Symbol" height="70" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none"></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>